P-glycoprotein, multidrug resistance and protein kinase C

Stem Cells

Volumn 14, Issue 1, 1996, Pages 47-55

  Fine, Robert L ^a,c   Chambers, Timothy C ^b   Sachs, Clifford W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c The New York Presbyterian Hospital   (United States)

Author keywords

Multidrug resistance; P glycoprotein; Protein kinase C

Indexed keywords

CALPHOSTIN A; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; SAFINGOL; STAUROSPORINE; TRIMETREXATE; VINCRISTINE;

APOPTOSIS; BREAST CANCER; ENZYME ACTIVITY; HUMAN; KIDNEY CARCINOMA; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW;

EID: 0030052091     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140047     Document Type: Review

References (50)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 1989;58:137-171.
2. Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 1988;79:285-296
3. Moscow JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 1988;80:14-20
4. Fojo AT, Ueda K, Slamon DJ et al. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-269.
5. Fine RL. Multidrug resistance. Cancer Chemother Biol Response Modif Ann 1989;10:73-84.
6. Fine RL, Koizumi S, Curt GA et al. Effect of calcium channel blockers human CFU-GM with cytotoxic drugs. J Clin Oncol 1987;5:489-495.
7. Fine RL, Patel J, Chabner BA. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 1988;85:582-586.
8. Ferguson PJ, Cheng YC. Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoyl phorbol-13-acetate. Cancer Res 1987;47:433-441.
9. Posada J, Vicki P, Tritton TR. Protein kinase C in Adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 1989;49:6634-6639.
10. Ward NE, O'Brian CA. Distinct patterns of phorbol ester induced downregulation of protein kinase C activity in Adriamycin selected multidrug resistant and parental fibrosarcoma cells. Cancer Lett 1991;58-189-193
11. Gollapudi S, Patel K, Jain V et al. Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. Cancer Lett 1992;62:69-75.
12. Aquino A, Hartman KD, Knode MC et al. Role of protein kinase C in phosphorylation of vinculin in Adriamycin-resistant HL-60 leukemia cells. Cancer Res 1988;48:3324-3329.
13. Posada JA, McKeegan EM, Worthington KF et al. Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Commun 1989;1:285-292.
14. Palayoor ST, Stein JM, Hait WN. Inhibition of protein kinase C by antineoplastic agents: implications for drug resistance. Biochem Biophys Res Commun 1987;148:718-725.
15. Chambers TC, Pohl J, Raynor RL et al. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 1993;268:4592-4595.
16. Orr GA, Han EKH, Browne PC et al. Identification of the major phosphorylation domain of murine mdr 1b P-glycoprotein. J Biol Chem 1993;268:25054-25062.
17. Asaoka Y, Nakamura S, Yoshida K et al. Protein kinase C. calcium, and phospholipid degradation. Trends Biochem Sci 1992;17:414-417.
18. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993;291:329-343.
19. Ido M, Sato K, Sakurai M et al. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemia cells resistant to etoposide. Cancer Res 1987;47:3460-3463.
20. Schwartz GK, Arkin H, Holland JF et al. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Cancer Res 1991;51:55-61.
21. Lee SA, Karaszkiewicz JW, Anderson WB. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 1992;52:3750-3759.
22. O'Brian CA, Fan D, Ward NE et al. Level of protein kinase C activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Lett 1989;246:78-82.
23. O'Brian CA, Fan D, Ward NE et al. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro. Biochem Pharmacol 1991;41:797-806.
24. Chambers T, McAvoy E, Jacobs J et al. PKC phosphorylates P-glycoprotein in MDR human KB carcinoma cells. J Biol Chem 1990;265:7679-7686.
25. r 170,000 to 180,000 glycoprotein specific to MDR tumor cells: effects of verapamil, trifluoperazine and phorbol esters. Cancer Res 1987;47:2860-2865.
26. Blobe GC, Sachs CW, Khan WA et al. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. J Biol Chem 1993;268:658-664.
27. Bates SE, Lee JS, Dickstein B et al. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 1993;32:9156-9164.
28. Chambers TC, Zheng B, Kuo JF. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol Pharmacol 1993;41:1008-1015.
29. Dong Z, Ward N, Fan D et al. In vitro model for intrinsic drug resistance: effects of PKC activators on the chemosensitivity of cultured human colon cancer cells. Mol Pharmacol 1991;39:563-569.
30. Sato W, Yusa K, Naito M et al. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 1990;173:1252-1257.
31. Ma L, Marquardt D, Takemoto L et al. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 1991;266:5593-5599.
32. Miyamoto K, Inoko K, Wakusawa S et al. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Cancer Res 1993;53:155-159.
33. Sachs CW, Safa A, Harrison SD et al. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J Biol Chem 1995;270:26639-26648.
34. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993;85:632-639.
35. 1 gene expression in human cells by protein kinase C agonists. Oncol Res 1992;4:281-290.
36. Cornwell MM, Smith DE. A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene C-raf kinase. J Biol Chem 1993;268:15347-15350.
37. Aquino A, Warren BS, Omichinski J et al. Protein kinase C-γ is present in Adriamycin-resistant HL-60 leukemia cells. Biochem Biophys Res Commun 1990;166:723-728.
38. Ahmad S, Glazer RI. Expressions of the antisense cDNA for protein kinase C attenuates resistance in doxorubicin-resistant MCF7 breast carcinoma cells. Mol Pharmacol 1993;43:858-882.
39. Yu G, Ahmad S, Aquino A et al. Transfection with protein kinase C confers increased multidrug resistance to MCF-7 cells overexpressing P-glycoprotein. Cancer Commun 1991;3:181-189.
40. Chambers TC, Chalikonda I, Elion G. Correlation of protein kinase C translocation and P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Commun 1990;169:253-259.
41. Fan D, Fidler IJ, Ward NE et al. Stable expression of a cDNA encoding rat brain protein kinase C-β confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 1992;12:661-668.
42. Ahmad S, Safa AR, Glazer RI. Modulation of P-glycoprotein by protein kinase Cα in a baculovirus expression system. Biochemistry 1994;33:10313-10318.
43. Efferth T, Volm M. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin. Anticancer Res 1992;12:2209-2212.
44. Mellado W, Horwitz SB. Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 1987;26:6900-6904.
45. Staats J, Marquardt D, Center MS. Characterization of a membrane-associated protein kinase of multidrus-resistant HL60 cells which phosphorylates P-glycoprotein. J Biol Chem 1990;265:4084-4090.
46. Lelong IH, Cardarelli CO, Gottesman MM et al. GTP stimulated phosphorylation of P-glycoprotein in transporting vesicles from KB-V1 multidrug resistant cells. Biochemistry 1994;33:8921-8929.
47. Hardy SP, Goodfellow HR, Valverde MA et al. Protein kinase C mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 1995;14:68-75.
48. Sachs CW, Blobe GC, Rao US et al. Phosphorylation of Pgp by PKC isoenzymes βI, βII inhibits drug stimulated ATPase activity in vitro. Proc Am Assoc Cancer Res 1995;35:352a.
49. Germann UA, Chambers TC, Ambudkar SV et at. Characterization of phosphorylation defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 1996 (in press).
50. Sachs CW, Chambers TC, Blobe GC et al. Phosphorylation of a synthetic P-glycoprotein peptide PG-2, by calcium dependent PKC isoenzymes. Proc Am Assoc Cancer Res 1995;36:334a.